The 2025 China Beijing International Sci-Tech Expo (Sci-Tech Expo), held from May 8-11, concluded successfully under the theme of "Technology Leading, Sharing the Future." As a major platform for global technological innovation, this year's event focused on cutting-edge fields such as artificial intelligence, digital education, medical health, and new energy, establishing a comprehensive platform for technology commercialization, industry resource matchmaking, and international cooperation expansion. In the core exhibition area, WBL Medical Group became a highlight with several innovative male health products, showcasing the innovative strength of Chinese medical technology companies.
WBL Medical Group: Breakthroughs in Male Health Treatment Technologies
As a representative enterprise in the medical health sector in Changping District, WBL Medical Group’s participation in the event was centered on the theme "Precision Medicine · Empowered by Technology," showcasing their groundbreaking achievements in male health treatment. Several key products attracted attention from numerous medical institutions, research institutes, and investment organizations due to their technological leadership and clinical value:
Low-Intensity Pulsed Ultrasound Therapy Device (LIPUS):
WBL LIPUS uses low-intensity pulsed ultrasound to activate cell signaling pathways, promoting tissue regeneration and repair. Its innovative advantage lies in directly repairing pathological damage, avoiding drug dependence, and being particularly suitable for refractory cases. Compared to surgery, it offers non-invasive, pain-free, and repeatable treatments. Clinical multi-center RCTs have confirmed its significant efficacy, and it has won the National Medical Device Innovation Award, establishing it as the gold standard for ED treatment, filling a technological gap in the field and leading a new paradigm in male health disease treatment.
Prostate Field Ablation Device:
This device adopts non-invasive treatment technology, using precision-targeted energy fields to ablate prostate lesions, achieving a breakthrough in non-invasive, efficient, and low-side-effect treatments. Its intelligent operating system dynamically adjusts treatment parameters according to individual patient differences, providing a new treatment option for patients with prostate diseases.
Penile Hardness Measurement Device:
As a precise diagnostic tool for male health diseases, this device uses high-precision sensor technology to quantitatively assess penile erection hardness and duration, providing objective data support for diagnosing erectile dysfunction (ED) and other conditions. Its portable design and intelligent analysis functions greatly enhance clinical diagnostic efficiency and accuracy.
During the exhibition, the WBL Medical Group's booth attracted professional visitors who came for hands-on experience and consultations.
WBL LIPUS Technology for Treating Erectile Dysfunction (ED)
The core mechanism of WBL LIPUS is the use of low-energy pulsed ultrasound (sound intensity range: 50-350mW/CM²) on the penile cavernous tissue to activate endogenous stem cells, promoting vascular and nerve regeneration, repairing damaged vascular endothelium and nerve matrix, thus improving erectile function at the pathological level. Compared to traditional oral medications (such as PDE5 inhibitors), prosthetic implants, or invasive treatments (such as intracavernosal injections), LIPUS does not rely on drugs or surgery, avoiding side effects and the inconvenience of repeated treatments.
WBL LIPUS Competitive Advantages
Compared to traditional ED treatments and similar products, WBL LIPUS offers the following advantages:
1.Non-Invasiveness and Safety
It does not require drugs or surgery, avoiding liver and kidney burdens and infection risks, especially suitable for patients with chronic conditions such as diabetes.
2.Comprehensive Treatment Model
The unique "LIPUS + Psychological Counseling + VR" multi-dimensional treatment approach integrates both physiological repair and psychological intervention, improving patient satisfaction by over 30%.
3.Clinical Data Support
Clinical validation from over 60 global medical institutions supports its efficacy and safety, with endorsements from authoritative organizations such as UCSF and Peking University Hospital.
Technology Leading, Building a Healthy Future Together
WBL Medical Group’s impressive presence at this year’s Sci-Tech Expo is not only a reflection of the innovative strength of Chinese medical technology companies but also a vivid portrayal of the thriving technology ecosystem in Changping District. Looking forward, with Changping District continuing to deepen global technological cooperation, innovative enterprises like WBL Medical Group will have broader development opportunities, contributing more "Chinese solutions" to the global male health treatment field.